{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:04:34Z","timestamp":1791839074501,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the science and technology plan of Jiangxi Provincial Administration of Traditional Chinese Medicine","award":["2022B1001"],"award-info":[{"award-number":["2022B1001"]}]},{"name":"the science and technology plan of Jiangxi Provincial Administration of Traditional Chinese Medicine","award":["2023B1221"],"award-info":[{"award-number":["2023B1221"]}]},{"name":"the Jiangxi Provincial Natural Science Foundation","award":["20232BAB206020"],"award-info":[{"award-number":["20232BAB206020"]}]},{"name":"the Jiangxi Provincial Natural Science Foundation","award":["20224BAB216022"],"award-info":[{"award-number":["20224BAB216022"]}]},{"name":"Science and Technology Plan of Jiangxi Provincial Health Commission","award":["202130202"],"award-info":[{"award-number":["202130202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14373-9","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:40:52Z","timestamp":1753278052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Single-cell perspective on the Monocyte-to-HDL cholesterol ratio as a metastasis biomarker in papillary thyroid cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhi-kun","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"6","key":"14373_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"14373_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/thy.2010.0021","volume":"21","author":"B Aschebrook-Kilfoy","year":"2011","unstructured":"Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992\u20132006. Thyroid. 2011;21(2):125\u201334. https:\/\/doi.org\/10.1089\/thy.2010.0021.","journal-title":"Thyroid"},{"issue":"9","key":"14373_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","volume":"6","author":"A Maniakas","year":"2020","unstructured":"Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, et al. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000\u20132019. JAMA Oncol. 2020;6(9):1397\u2013404. https:\/\/doi.org\/10.1001\/jamaoncol.2020.3362.","journal-title":"JAMA Oncol"},{"issue":"7","key":"14373_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara CM, Schneider AB. Epidemiology of Thyroid Cancer. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1284\u201397. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-1440.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"14373_CR5","doi-asserted-by":"publisher","unstructured":"Qin C, Cai S, Yin M, Ma B, Shen C, Zhang Y, et al. Association of Lymph Nodes Positive Rate With the Risk of Recurrence in Patients With Stage T1 Papillary Thyroid Cancer. J Endocr Soc. 2024;8(8):bvae131. https:\/\/doi.org\/10.1210\/jendso\/bvae131.","DOI":"10.1210\/jendso\/bvae131"},{"issue":"8","key":"14373_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cac2.12193","volume":"41","author":"FH Wang","year":"2021","unstructured":"Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond). 2021;41(8):747\u201395. https:\/\/doi.org\/10.1002\/cac2.12193.","journal-title":"Cancer Commun (Lond)"},{"key":"14373_CR7","doi-asserted-by":"publisher","unstructured":"Wu X, Li BL, Zheng CJ, He XD. Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma. World J Clin Cases. 2020;8(8):1350\u201360. https:\/\/doi.org\/10.12998\/wjcc.v8.i8.1350.","DOI":"10.12998\/wjcc.v8.i8.1350"},{"key":"14373_CR8","doi-asserted-by":"publisher","first-page":"153303382199005","DOI":"10.1177\/1533033821990055","volume":"20","author":"X Zhang","year":"2021","unstructured":"Zhang X, Li S, Wang J, Liu F, Zhao Y. Relationship Between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma. Technol Cancer Res Treat. 2021;20:1533033821990055. https:\/\/doi.org\/10.1177\/1533033821990055.","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"14373_CR9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ijc.31944","volume":"144","author":"E Song","year":"2019","unstructured":"Song E, Oh HS, Jeon MJ, Chung KW, Hong SJ, Ryu JS, et al. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma. Int J Cancer. 2019;144(6):1414\u201320. https:\/\/doi.org\/10.1002\/ijc.31944.","journal-title":"Int J Cancer"},{"issue":"6","key":"14373_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s11154-023-09845-x","volume":"24","author":"E Russo","year":"2023","unstructured":"Russo E, Guizzardi M, Canali L, Gaino F, Costantino A, Mazziotti G, et al. Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2023;24(6):1205\u201316. https:\/\/doi.org\/10.1007\/s11154-023-09845-x.","journal-title":"Rev Endocr Metab Disord"},{"issue":"8","key":"14373_CR11","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11255-014-0730-1","volume":"46","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619\u201325. https:\/\/doi.org\/10.1007\/s11255-014-0730-1.","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"14373_CR12","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1002\/jcp.27028","volume":"233","author":"S Ganjali","year":"2018","unstructured":"Ganjali S, Gotto AM Jr, Ruscica M, Atkin SL, Butler AE, Banach M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237\u201346. https:\/\/doi.org\/10.1002\/jcp.27028.","journal-title":"J Cell Physiol"},{"issue":"11","key":"14373_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24014","volume":"35","author":"H Xu","year":"2021","unstructured":"Xu H, Pang Y, Li X, Zha B, He T, Ding H. Monocyte to high-density lipoprotein cholesterol ratio as an independent risk factor for papillary thyroid carcinoma. J Clin Lab Anal. 2021;35(11): e24014. https:\/\/doi.org\/10.1002\/jcla.24014.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"14373_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12944-020-1196-z","volume":"19","author":"XZ Liu","year":"2020","unstructured":"Liu XZ, Wang JM, Ji YX, Zhao DB. Monocyte-to-high-density lipoprotein cholesterol ratio is associated with the presence and size of thyroid nodule irrespective of the gender. Lipids Health Dis. 2020;19(1):36. https:\/\/doi.org\/10.1186\/s12944-020-1196-z.","journal-title":"Lipids Health Dis"},{"key":"14373_CR15","doi-asserted-by":"publisher","first-page":"117955492311999","DOI":"10.1177\/11795549231199920","volume":"17","author":"Y Hu","year":"2023","unstructured":"Hu Y, Shen Y, Xia E, Hirachan S, Bhandari A, Jin Z. Monocyte-to-High-Density Lipoprotein Cholesterol Ratio Together With the Lymphocyte-to-Monocyte Ratio in Predicting the Malignancy of the Thyroid Nodule in Patients Complicated With Type 2 Diabetes. Clin Med Insights Oncol. 2023;17:11795549231199920. https:\/\/doi.org\/10.1177\/11795549231199920.","journal-title":"Clin Med Insights Oncol"},{"key":"14373_CR16","doi-asserted-by":"publisher","unstructured":"Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, et al. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest. 2023;133(11). https:\/\/doi.org\/10.1172\/JCI169653.","DOI":"10.1172\/JCI169653"},{"key":"14373_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840811","volume":"13","author":"T Wang","year":"2022","unstructured":"Wang T, Shi J, Li L, Zhou X, Zhang H, Zhang X, et al. Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma. Front Immunol. 2022;13: 840811. https:\/\/doi.org\/10.3389\/fimmu.2022.840811.","journal-title":"Front Immunol"},{"key":"14373_CR18","doi-asserted-by":"publisher","unstructured":"Minna E, Brich S, Todoerti K, Pilotti S, Collini P, Bonaldi E, et al. Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers (Basel). 2020;12(1). https:\/\/doi.org\/10.3390\/cancers12010112.","DOI":"10.3390\/cancers12010112"},{"issue":"7","key":"14373_CR19","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-15-2351","volume":"76","author":"LA Jolly","year":"2016","unstructured":"Jolly LA, Novitskiy S, Owens P, Massoll N, Cheng N, Fang W, et al. Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss. Cancer Res. 2016;76(7):1804\u201313. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2351.","journal-title":"Cancer Res"},{"key":"14373_CR20","doi-asserted-by":"publisher","unstructured":"Avagliano A, Fiume G, Bellevicine C, Troncone G, Venuta A, Acampora V, et al. Thyroid Cancer and Fibroblasts. Cancers (Basel). 2022;14(17). https:\/\/doi.org\/10.3390\/cancers14174172.","DOI":"10.3390\/cancers14174172"},{"issue":"1","key":"14373_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1186\/s12885-024-12459-4","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li X, Gang Q, Huang Y, Liu M, Zhang H, et al. Pathomics and single-cell analysis of papillary thyroid carcinoma reveal the pro-metastatic influence of cancer-associated fibroblasts. BMC Cancer. 2024;24(1):710. https:\/\/doi.org\/10.1186\/s12885-024-12459-4.","journal-title":"BMC Cancer"},{"issue":"4","key":"14373_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10585-020-10041-3","volume":"37","author":"A Spanopoulou","year":"2020","unstructured":"Spanopoulou A, Gkretsi V. Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients. Clin Exp Metastasis. 2020;37(4):451\u201364. https:\/\/doi.org\/10.1007\/s10585-020-10041-3.","journal-title":"Clin Exp Metastasis"},{"key":"14373_CR23","doi-asserted-by":"publisher","unstructured":"Joo M, Kim D, Lee MW, Lee HJ, Kim JM. GDF15 Promotes Cell Growth, Migration, and Invasion in Gastric Cancer by Inducing STAT3 Activation. Int J Mol Sci. 2023;24(3). https:\/\/doi.org\/10.3390\/ijms24032925.","DOI":"10.3390\/ijms24032925"},{"issue":"5","key":"14373_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1089\/thy.2020.0034","volume":"31","author":"YE Kang","year":"2021","unstructured":"Kang YE, Kim JM, Lim MA, Lee SE, Yi S, Kim JT, et al. Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness. Thyroid. 2021;31(5):772\u201386. https:\/\/doi.org\/10.1089\/thy.2020.0034.","journal-title":"Thyroid"},{"key":"14373_CR25","doi-asserted-by":"publisher","unstructured":"Silva-Bermudez LS, Kluter H, Kzhyshkowska JG. Macrophages as a Source and Target of GDF-15. Int J Mol Sci. 2024;25(13). https:\/\/doi.org\/10.3390\/ijms25137313.","DOI":"10.3390\/ijms25137313"},{"issue":"6","key":"14373_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri3671","volume":"14","author":"F Ginhoux","year":"2014","unstructured":"Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. 2014;14(6):392\u2013404. https:\/\/doi.org\/10.1038\/nri3671.","journal-title":"Nat Rev Immunol"},{"key":"14373_CR27","doi-asserted-by":"publisher","unstructured":"Dash SP, Gupta S, Sarangi PP. Monocytes and macrophages: Origin, homing, differentiation, and functionality during inflammation. Heliyon. 2024;10(8):e29686. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29686.","DOI":"10.1016\/j.heliyon.2024.e29686"},{"issue":"10","key":"14373_CR28","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26461","volume":"233","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Zou W, Du J, Zhao Y. The origins and homeostasis of monocytes and tissue-resident macrophages in physiological situation. J Cell Physiol. 2018;233(10):6425\u201339. https:\/\/doi.org\/10.1002\/jcp.26461.","journal-title":"J Cell Physiol"},{"key":"14373_CR29","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","volume":"10","author":"M Gschwandtner","year":"2019","unstructured":"Gschwandtner M, Derler R, Midwood KS. More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis. Front Immunol. 2019;10:2759. https:\/\/doi.org\/10.3389\/fimmu.2019.02759.","journal-title":"Front Immunol"},{"issue":"1","key":"14373_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-7771-2-1","volume":"2","author":"J Yang","year":"2014","unstructured":"Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res. 2014;2(1):1. https:\/\/doi.org\/10.1186\/2050-7771-2-1.","journal-title":"Biomark Res"},{"issue":"2","key":"14373_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.it.2018.11.007","volume":"40","author":"DA Hume","year":"2019","unstructured":"Hume DA, Irvine KM, Pridans C. The Mononuclear Phagocyte System: The Relationship between Monocytes and Macrophages. Trends Immunol. 2019;40(2):98\u2013112. https:\/\/doi.org\/10.1016\/j.it.2018.11.007.","journal-title":"Trends Immunol"},{"issue":"6657","key":"14373_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill R, Wirapati P, Messemaker M, Roh W, Zitti B, Duval F, et al. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science. 2023;381(6657):515\u201324. https:\/\/doi.org\/10.1126\/science.ade2292.","journal-title":"Science"},{"issue":"2","key":"14373_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cellsig.2013.11.004","volume":"26","author":"D Zhou","year":"2014","unstructured":"Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C, et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal. 2014;26(2):192\u20137. https:\/\/doi.org\/10.1016\/j.cellsig.2013.11.004.","journal-title":"Cell Signal"},{"issue":"1","key":"14373_CR34","doi-asserted-by":"publisher","first-page":"16554","DOI":"10.1038\/s41598-020-73624-w","volume":"10","author":"M Oshi","year":"2020","unstructured":"Oshi M, Tokumaru Y, Asaoka M, Yan L, Satyananda V, Matsuyama R, et al. M1 Macrophage and M1\/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer. Sci Rep. 2020;10(1):16554. https:\/\/doi.org\/10.1038\/s41598-020-73624-w.","journal-title":"Sci Rep"},{"issue":"15","key":"14373_CR35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1042\/CS20220531","volume":"137","author":"Z Strizova","year":"2023","unstructured":"Strizova Z, Benesova I, Bartolini R, Novysedlak R, Cecrdlova E, Foley LK, et al. M1\/M2 macrophages and their overlaps - myth or reality? Clin Sci (Lond). 2023;137(15):1067\u201393. https:\/\/doi.org\/10.1042\/CS20220531.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"14373_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13059-024-03292-w","volume":"25","author":"M Hu","year":"2024","unstructured":"Hu M, Chikina M. Heterogeneous pseudobulk simulation enables realistic benchmarking of cell-type deconvolution methods. Genome Biol. 2024;25(1):169. https:\/\/doi.org\/10.1186\/s13059-024-03292-w.","journal-title":"Genome Biol"},{"issue":"12","key":"14373_CR37","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1210\/jcem.80.12.8530576","volume":"80","author":"S Matsubayashi","year":"1995","unstructured":"Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, et al. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab. 1995;80(12):3421\u20134. https:\/\/doi.org\/10.1210\/jcem.80.12.8530576.","journal-title":"J Clin Endocrinol Metab"},{"key":"14373_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/125450","volume":"2014","author":"LS Ward","year":"2014","unstructured":"Ward LS. Immune response in thyroid cancer: widening the boundaries. Scientifica (Cairo). 2014;2014: 125450. https:\/\/doi.org\/10.1155\/2014\/125450.","journal-title":"Scientifica (Cairo)"},{"issue":"1","key":"14373_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-018-0786-0","volume":"17","author":"GE Naoum","year":"2018","unstructured":"Naoum GE, Morkos M, Kim B, Arafat W. Novel targeted therapies and immunotherapy for advanced thyroid cancers. Mol Cancer. 2018;17(1):51. https:\/\/doi.org\/10.1186\/s12943-018-0786-0.","journal-title":"Mol Cancer"},{"key":"14373_CR40","doi-asserted-by":"publisher","unstructured":"Varricchi G, Loffredo S, Marone G, Modestino L, Fallahi P, Ferrari SM, et al. The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition. Int J Mol Sci. 2019;20(16). https:\/\/doi.org\/10.3390\/ijms20163934.","DOI":"10.3390\/ijms20163934"},{"key":"14373_CR41","doi-asserted-by":"publisher","unstructured":"Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, et al. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment. Int J Mol Sci. 2019;20(18). https:\/\/doi.org\/10.3390\/ijms20184413.","DOI":"10.3390\/ijms20184413"},{"key":"14373_CR42","doi-asserted-by":"publisher","first-page":"1325575","DOI":"10.3389\/fonc.2024.1325575","volume":"14","author":"MH Huo","year":"2024","unstructured":"Huo MH, Adeerjiang Y, Abulitipu A, Khan U, Li XX, Zhang L, et al. Th17\/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target. Front Oncol. 2024;14:1325575. https:\/\/doi.org\/10.3389\/fonc.2024.1325575.","journal-title":"Front Oncol"},{"issue":"1","key":"14373_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-019-1198-8","volume":"38","author":"M Mazzoni","year":"2019","unstructured":"Mazzoni M, Mauro G, Erreni M, Romeo P, Minna E, Vizioli MG, et al. Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism. J Exp Clin Cancer Res. 2019;38(1):208. https:\/\/doi.org\/10.1186\/s13046-019-1198-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"14373_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.875384","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu Q, Sun W, Zhang H. Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer. Front Pharmacol. 2022;13: 875384. https:\/\/doi.org\/10.3389\/fphar.2022.875384.","journal-title":"Front Pharmacol"},{"issue":"1","key":"14373_CR45","doi-asserted-by":"publisher","first-page":"13288","DOI":"10.1038\/s41598-019-49613-z","volume":"9","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Sun HJ, Song YS, Yoo SK, Kim YA, Seo JS, et al. CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer. Sci Rep. 2019;9(1):13288. https:\/\/doi.org\/10.1038\/s41598-019-49613-z.","journal-title":"Sci Rep"},{"issue":"2","key":"14373_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/ERC-15-0196","volume":"23","author":"SW Cho","year":"2016","unstructured":"Cho SW, Kim YA, Sun HJ, Kim YA, Oh BC, Yi KH, et al. CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma. Endocr Relat Cancer. 2016;23(2):113\u201324. https:\/\/doi.org\/10.1530\/ERC-15-0196.","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"14373_CR47","doi-asserted-by":"publisher","first-page":"R465","DOI":"10.1530\/ERC-19-0163","volume":"26","author":"F Coperchini","year":"2019","unstructured":"Coperchini F, Croce L, Marino M, Chiovato L, Rotondi M. Role of chemokine receptors in thyroid cancer and immunotherapy. Endocr Relat Cancer. 2019;26(8):R465\u201378. https:\/\/doi.org\/10.1530\/ERC-19-0163.","journal-title":"Endocr Relat Cancer"},{"key":"14373_CR48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fendo.2018.00314","volume":"9","author":"M Rotondi","year":"2018","unstructured":"Rotondi M, Coperchini F, Latrofa F, Chiovato L. Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player? Front Endocrinol (Lausanne). 2018;9:314. https:\/\/doi.org\/10.3389\/fendo.2018.00314.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"14373_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","volume":"31","author":"Q Liu","year":"2016","unstructured":"Liu Q, Li A, Tian Y, Wu JD, Liu Y, Li T, et al. The CXCL8-CXCR1\/2 pathways in cancer. Cytokine Growth Factor Rev. 2016;31:61\u201371. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.08.002.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"14373_CR50","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41420-024-02157-2","volume":"10","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xu S. High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks. Cell Death Discov. 2024;10(1):378. https:\/\/doi.org\/10.1038\/s41420-024-02157-2.","journal-title":"Cell Death Discov"},{"issue":"6","key":"14373_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101043","volume":"14","author":"SS Mayengbam","year":"2021","unstructured":"Mayengbam SS, Singh A, Pillai AD, Bhat MK. Influence of cholesterol on cancer progression and therapy. Transl Oncol. 2021;14(6): 101043. https:\/\/doi.org\/10.1016\/j.tranon.2021.101043.","journal-title":"Transl Oncol"},{"key":"14373_CR52","doi-asserted-by":"publisher","first-page":"1291445","DOI":"10.3389\/fendo.2023.1291445","volume":"14","author":"Q Ma","year":"2023","unstructured":"Ma Q, Li Y, An L, Guo L, Liu X. Assessment of causal association between differentiated thyroid cancer and disordered serum lipid profile: a Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1291445. https:\/\/doi.org\/10.3389\/fendo.2023.1291445.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"14373_CR53","doi-asserted-by":"publisher","unstructured":"Revilla G, Ruiz-Auladell L, Vallverdu NF, Santamaria P, Moral A, Perez JI, et al. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells. Int J Mol Sci. 2023;24(13). https:\/\/doi.org\/10.3390\/ijms241311153.","DOI":"10.3390\/ijms241311153"},{"key":"14373_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.508126","volume":"10","author":"J Zhao","year":"2020","unstructured":"Zhao J, Tian Y, Yao J, Gu H, Zhang R, Wang H, et al. Hypercholesterolemia Is an Associated Factor for Risk of Differentiated Thyroid Cancer in Chinese Population. Front Oncol. 2020;10: 508126. https:\/\/doi.org\/10.3389\/fonc.2020.508126.","journal-title":"Front Oncol"},{"key":"14373_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111129","volume":"168","author":"Z HajiEsmailPoor","year":"2023","unstructured":"HajiEsmailPoor Z, Kargar Z, Tabnak P. Radiomics diagnostic performance in predicting lymph node metastasis of papillary thyroid carcinoma: A systematic review and meta-analysis. Eur J Radiol. 2023;168: 111129. https:\/\/doi.org\/10.1016\/j.ejrad.2023.111129.","journal-title":"Eur J Radiol"},{"issue":"8","key":"14373_CR56","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1016\/j.acra.2024.03.012","volume":"31","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu R, Wang Y, Zhang Y, Li M, Wang Y, et al. Ultrasound-Base Radiomics for Discerning Lymph Node Metastasis in Thyroid Cancer: A Systematic Review and Meta-analysis. Acad Radiol. 2024;31(8):3118\u201330. https:\/\/doi.org\/10.1016\/j.acra.2024.03.012.","journal-title":"Acad Radiol"},{"issue":"1","key":"14373_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12880-022-00809-2","volume":"22","author":"Y Tong","year":"2022","unstructured":"Tong Y, Zhang J, Wei Y, Yu J, Zhan W, Xia H, et al. Ultrasound-based radiomics analysis for preoperative prediction of central and lateral cervical lymph node metastasis in papillary thyroid carcinoma: a multi-institutional study. BMC Med Imaging. 2022;22(1):82. https:\/\/doi.org\/10.1186\/s12880-022-00809-2.","journal-title":"BMC Med Imaging"},{"issue":"12","key":"14373_CR58","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1016\/j.acra.2023.03.039","volume":"30","author":"L Dong","year":"2023","unstructured":"Dong L, Han X, Yu P, Zhang W, Wang C, Sun Q, et al. CT Radiomics-Based Nomogram for Predicting the Lateral Neck Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Prospective Multicenter Study. Acad Radiol. 2023;30(12):3032\u201346. https:\/\/doi.org\/10.1016\/j.acra.2023.03.039.","journal-title":"Acad Radiol"},{"key":"14373_CR59","doi-asserted-by":"publisher","unstructured":"Zhang Z, Xia F, Wang W, Huang Y, Li X. The systemic immune-inflammation index-based model is an effective biomarker on predicting central lymph node metastasis in clinically nodal-negative papillary thyroid carcinoma. Gland Surg. 2021;10(4):1368\u201373. https:\/\/doi.org\/10.21037\/gs-20-666.","DOI":"10.21037\/gs-20-666"},{"key":"14373_CR60","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.2147\/IJGM.S461708","volume":"17","author":"Y Gu","year":"2024","unstructured":"Gu Y, Yu M, Deng J, Lai Y. The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma. Int J Gen Med. 2024;17:2887\u201397. https:\/\/doi.org\/10.2147\/IJGM.S461708.","journal-title":"Int J Gen Med"},{"issue":"4","key":"14373_CR61","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3803\/EnM.2015.30.4.494","volume":"30","author":"SM Kim","year":"2015","unstructured":"Kim SM, Kim EH, Kim BH, Kim JH, Park SB, Nam YJ, et al. Association of the Preoperative Neutrophil-to-ymphocyte Count Ratio and Platelet-to-Lymphocyte Count Ratio with Clinicopathological Characteristics in Patients with Papillary Thyroid Cancer. Endocrinol Metab (Seoul). 2015;30(4):494\u2013501. https:\/\/doi.org\/10.3803\/EnM.2015.30.4.494.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6","key":"14373_CR62","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3109\/07853890.2010.497767","volume":"42","author":"B Pamukcu","year":"2010","unstructured":"Pamukcu B, Lip GY, Devitt A, Griffiths H, Shantsila E. The role of monocytes in atherosclerotic coronary artery disease. Ann Med. 2010;42(6):394\u2013403. https:\/\/doi.org\/10.3109\/07853890.2010.497767.","journal-title":"Ann Med"},{"issue":"8","key":"14373_CR63","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","volume":"95","author":"PJ Barter","year":"2004","unstructured":"Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004;95(8):764\u201372. https:\/\/doi.org\/10.1161\/01.RES.0000146094.59640.13.","journal-title":"Circ Res"},{"issue":"17","key":"14373_CR64","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1073\/pnas.1016086108","volume":"108","author":"JE Feig","year":"2011","unstructured":"Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, et al. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc Natl Acad Sci U S A. 2011;108(17):7166\u201371. https:\/\/doi.org\/10.1073\/pnas.1016086108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"14373_CR65","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bph.13319","volume":"173","author":"MK Lee","year":"2016","unstructured":"Lee MK, Moore XL, Fu Y, Al-Sharea A, Dragoljevic D, Fernandez-Rojo MA, et al. High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1. Br J Pharmacol. 2016;173(4):741\u201351. https:\/\/doi.org\/10.1111\/bph.13319.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"14373_CR66","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2013.12.168","volume":"172","author":"S Colin","year":"2014","unstructured":"Colin S, Fanchon M, Belloy L, Bochem AE, Copin C, Derudas B, et al. HDL does not influence the polarization of human monocytes toward an alternative phenotype. Int J Cardiol. 2014;172(1):179\u201384. https:\/\/doi.org\/10.1016\/j.ijcard.2013.12.168.","journal-title":"Int J Cardiol"},{"issue":"5","key":"14373_CR67","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00281-013-0387-3","volume":"35","author":"P Libby","year":"2013","unstructured":"Libby P, Nahrendorf M, Swirski FK. Monocyte heterogeneity in cardiovascular disease. Semin Immunopathol. 2013;35(5):553\u201362. https:\/\/doi.org\/10.1007\/s00281-013-0387-3.","journal-title":"Semin Immunopathol"},{"issue":"Pt 3","key":"14373_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140826","volume":"306","author":"J He","year":"2025","unstructured":"He J, Dai Y, Xu F, Huang X, Gao Y, Liu L, et al. High-density lipoprotein-based nanoplatforms for macrophage-targeted diagnosis and therapy of atherosclerosis. Int J Biol Macromol. 2025;306(Pt 3): 140826. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140826.","journal-title":"Int J Biol Macromol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14373-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14373-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:40:53Z","timestamp":1753278053000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14373-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14373"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14373-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Medical Ethics Committee of the First Affiliated Hospital of Nanchang University, and this study followed the ethical standards laid down in the 1964 Declaration of Helsinki. This ethics committee strictly follows China\u2019s Good Clinical Practice (CCP) and related regulations. Written informed consent was obtained from participants to collect and analyze specimens. This research was approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University (project approval number: ITS2024783).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1203"}}